Discovery of a long-acting nanocrystal formulation of INND-2201, a new co-drug of pregabalin and palmitoylethanolamide with synergistic analgesic effects.

Pharm Sci Adv · 2025 · PMC12709873 · PMID 41550657

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In agreement with previous reports [ 58 ], pregabalin (30 mg/kg) showed a trend to reduce the retention time on rotarod compared in rats.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.